MB21D2 and cancer: These results support our hypothesis that MB21D2 overexpression serves as a selective force to select and enrich cell clones with additional survival advantages, and the blockage of MB21D2 activity could be utilized as a strategy for treating cancer cells with MB21D2 overexpression.